ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q4 2019. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,655 | -14.7% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $1,940 | +94.0% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -66.7% | 500 | -66.7% | 0.00% | – |
| Q4 2020 | $3,000 | -66.7% | 1,500 | -50.0% | 0.00% | -100.0% |
| Q1 2020 | $9,000 | -25.0% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | +50.0% | 3,000 | +50.0% | 0.00% | – |
| Q3 2019 | $8,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | 0.0% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $8,000 | +60.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -58.3% | 2,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $12,000 | -29.4% | 2,000 | -27.3% | 0.00% | 0.0% |
| Q2 2018 | $17,000 | +112.5% | 2,750 | +61.8% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | +300.0% | 1,700 | +142.9% | 0.00% | – |
| Q4 2017 | $2,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |